You are here

  • Home
  • Archive
  • Volume 10, Issue 5
  • NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer

 

Online download statistics by month:

Online download statistics by month: May 2022 to July 2025

AbstractFullPdf
May 2022889920424
Jun 2022481507261
Jul 202225726585
Aug 2022301314171
Sep 2022302304138
Oct 2022278280103
Nov 202214614776
Dec 202212612645
Jan 202311811938
Feb 202313914178
Mar 2023919171
Apr 2023979772
May 2023505143
Jun 2023575735
Jul 2023717147
Aug 2023606231
Sep 2023686839
Oct 2023606054
Nov 2023696933
Dec 2023909169
Jan 2024656556
Feb 202412912951
Mar 202420320495
Apr 2024717240
May 2024747532
Jun 2024838240
Jul 202410210350
Aug 2024383729
Sep 202445461230
Oct 2024636336
Nov 2024283030
Dec 2024363929
Jan 2025555535
Feb 2025434330
Mar 2025434335
Apr 2025454537
May 2025505127
Jun 2025353513
Jul 2025110
Total495950583808